Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Patients' and partners' views of care and treatment provided for metastatic castrate-resistant prostate cancer in the UK

Catt, Susan, Matthews, Lucy, May, Shirley, Payne, Heather, Mason, Malcolm ORCID: https://orcid.org/0000-0003-1505-2869 and Jenkins, Valerie 2019. Patients' and partners' views of care and treatment provided for metastatic castrate-resistant prostate cancer in the UK. European Journal of Cancer Care 28 (6) , e13140. 10.1111/ecc.13140

[thumbnail of Authors' submission copy accepted for publication by EJCC on 24.07.19.pdf]
Preview
PDF - Accepted Post-Print Version
Download (747kB) | Preview

Abstract

Objective Documentations of the experiences of patients with advanced prostate cancer and their partners are sparse. Views of care and treatment received for metastatic castrate‐resistant prostate cancer (mCRPC) are presented here. Methods Structured interviews conducted within 14 days of a systemic therapy for mCRPC starting and 3 months later explored the following: treatment decisions, information provision, perceived benefits and harms of treatment, and effects of these on patients’ and partners’ lives. Results Thirty‐seven patients and 33 partners recruited from UK cancer centres participated. The majority of patients (46%) reported pain was their worst symptom and many wanted to discuss its management (baseline‐50%; 3 months‐33%). Patients and partners believed treatment would delay progression (>75%), improve wellbeing (33%), alleviate pain (≈12%) and extend life (15% patients, 36% partners). At 3 months, most men (42%) said fatigue was the worst treatment‐related side effect (SE), 27% experienced unexpected SEs and 54% needed help with SEs. Most patients received SE information (85% written; 75% verbally); many additionally searched the Internet (33% patients; 55% partners). Only 54% of patients said nurse support was accessible. Conclusion Pain and other symptom management are not optimal. Increased specialist nurse provision and earlier palliative care links are needed. Dedicated clinics may be justified.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Wiley
ISSN: 0961-5423
Date of First Compliant Deposit: 19 March 2020
Date of Acceptance: 24 July 2019
Last Modified: 09 Jan 2024 17:51
URI: https://orca.cardiff.ac.uk/id/eprint/130513

Citation Data

Cited 6 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics